Angionetics Inc.   Report issue

For profit Phase 3
Founded: San Diego CA United States (2015)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2017
NCT02928094
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now